A new anchor point for gut microbiome to regulate complications of allogeneic hematopoietic stem cell transplantation: oxidative stress. — ME/CFS Atlas
E3 PreliminaryPreliminaryPEM not requiredReview-NarrativePeer-reviewedReviewed
Standard · 3 min
A new anchor point for gut microbiome to regulate complications of allogeneic hematopoietic stem cell transplantation: oxidative stress.
Bai, Wenxuan, Jiang, Tiebin, Tang, Lanlan et al. · Experimental hematology · 2025 · DOI
Quick Summary
This review examines how bone marrow stem cell transplants can cause complications through a process called oxidative stress (cellular damage from harmful molecules). The authors explain how gut bacteria and their chemical byproducts may help protect the body by reducing this oxidative stress, potentially preventing or lessening serious complications like infections, fatigue, and organ damage that can occur after transplantation.
Why It Matters
This review is relevant to ME/CFS research because it identifies oxidative stress and gut microbiome dysfunction as potential mechanisms underlying post-transplant chronic fatigue syndrome, suggesting that microbiome-targeted interventions may help prevent or treat fatigue in this population. Understanding how gut bacteria influence systemic oxidative stress could inform new therapeutic approaches for ME/CFS patients more broadly, as oxidative stress has been implicated in ME/CFS pathophysiology.
Observed Findings
Chemotherapy and radiation pretreatment for allo-HSCT generates high levels of reactive oxygen species (ROS) in the bone marrow microenvironment
Gut microbiome-derived metabolites including short-chain fatty acids, secondary bile acids, hydrogen sulfide, and nitric oxide can cross the intestinal epithelium and enter systemic circulation
Oxidative stress in the bone marrow is associated with development of multiple allo-HSCT complications including infection, relapse, GVHD, graft failure, and thrombocytopenia
Chronic fatigue syndrome is listed as one documented complication of allo-HSCT linked to oxidative stress
Inferred Conclusions
The gut microbiome serves as a regulatory 'anchor point' that modulates systemic oxidative stress and thereby influences the severity of allo-HSCT complications
Microbiome-derived metabolites have protective effects against oxidative stress-mediated complications following transplantation
Targeting the gut microbiome to enhance production of protective metabolites may represent a novel preventive or therapeutic strategy for allo-HSCT complications including chronic fatigue
Remaining Questions
Which specific microbiota compositions or metabolite profiles are most protective against oxidative stress-induced complications in allo-HSCT patients?
Can microbiome-targeted interventions (prebiotics, probiotics, dietary modification) effectively reduce oxidative stress and improve outcomes in prospective clinical trials?
What This Study Does Not Prove
This review does not provide direct clinical evidence that modifying the gut microbiome actually reduces oxidative stress or prevents complications in allo-HSCT patients—it synthesizes existing literature to propose mechanisms. It does not establish causation between oxidative stress and specific complications, nor does it demonstrate that the findings apply to spontaneous ME/CFS outside the transplant setting. The proposed role of gut microbiota is theoretical and requires prospective testing.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.